HC Wainwright Forecasts Strong Price Appreciation for Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock
Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) had its price target upped by HC Wainwright from $200.00 to $217.00 in a research note issued to investors on Monday,Benzinga reports. HC Wainwright currently has a buy rating on the specialty pharmaceutical company’s stock. A number of other brokerages have also issued reports on JAZZ. JPMorgan Chase & […]
Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) had its price target upped by HC Wainwright from $200.00 to $217.00 in a research note issued to investors on Monday,Benzinga reports. HC Wainwright currently has a buy rating on the specialty pharmaceutical company’s stock. A number of other brokerages have also issued reports on JAZZ. JPMorgan Chase & […]
